SKIN - The Beauty Health Company Stock Price, Fair Value and News

$1.390.00 (0.00%)

Delayed as of 22 Nov 2024, 11:03 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SKIN Price Action

Last 7 days

-22.9%

Last 30 days

-17.4%

Last 90 days

-20.2%

Trailing 12 Months

-37.8%

SKIN RSI Chart

SKIN Valuation

Market Cap

172.5M

Price/Earnings (Trailing)

-6.12

Price/Sales (Trailing)

0.5

EV/EBITDA

-25.44

Price/Free Cashflow

-27.75

SKIN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SKIN Fundamentals

SKIN Revenue

Revenue (TTM)

347.6M

Rev. Growth (Yr)

-19.11%

Rev. Growth (Qtr)

-13.02%

SKIN Earnings

Earnings (TTM)

-28.2M

Earnings Growth (Yr)

75.22%

Earnings Growth (Qtr)

-9.2K%

SKIN Profitability

Operating Margin

50.53%

EBT Margin

-7.66%

Return on Equity

-47.17%

Return on Assets

-4.03%

Free Cashflow Yield

-3.6%

SKIN Investor Care

Buy Backs (1Y)

5.44%

Diluted EPS (TTM)

-0.43

SKIN Alerts

JANUS HENDERSON GROUP PLC reported owning 10.3% of SKIN [2024-11-14]

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	393.1M	366.2M	347.6M	0
2023	376.7M	390.7M	399.3M	398.0M
2022	288.0M	325.0M	345.6M	365.9M
2021	306.5M	358.9M	392.5M	260.1M
2020	0	150.8M	134.9M	119.1M
2019	0	0	0	166.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About The Beauty Health Company

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

CEO	Mr. Andrew Stanleick
WEBSITE	beautyhealth.com
SECTOR	Consumer Defensive
INDUSTRY	Household & Personal Products
EMPLOYEES	1034

The Beauty Health Company Frequently Asked Questions

What is the ticker symbol for The Beauty Health Company? What does SKIN stand for in stocks?

SKIN is the stock ticker symbol of The Beauty Health Company. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of The Beauty Health Company (SKIN)?

As of Thu Nov 21 2024, market cap of The Beauty Health Company is 172.53 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SKIN stock?

You can check SKIN's fair value in chart for subscribers.

Is The Beauty Health Company a good stock to buy?

The fair value guage provides a quick view whether SKIN is over valued or under valued. Whether The Beauty Health Company is cheap or expensive depends on the assumptions which impact The Beauty Health Company's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SKIN.

What is The Beauty Health Company's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, SKIN's PE ratio (Price to Earnings) is -6.12 and Price to Sales (PS) ratio is 0.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SKIN PE ratio will change depending on the future growth rate expectations of investors.